Debra Zack
Geen lopende functies
Vermogen: 174 135 $ op 31-03-2024
Profiel
Debra Jeske Zack worked as an Executive Director-Global Product Area at Amgen, Inc. and as a Vice President-Clinical Development at Xencor, Inc. Prior to that, she was an Associate Professor at the University of California, Los Angeles.
She also served as the Chief Medical Officer at Exagen, Inc. from 2020 to 2022.
Dr. Zack received her undergraduate degree from Texas Christian University and her doctorate from The University of Texas Southwestern Medical Center.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
EXAGEN, INC.
0.64% | 18-04-2023 | 109 519 ( 0.64% ) | 174 135 $ | 31-03-2024 |
Eerdere bekende functies van Debra Zack
| Bedrijven | Functie | Einde |
|---|---|---|
| EXAGEN INC. | Chief Tech/Sci/R&D Officer | 05-12-2022 |
| University of California, Los Angeles | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
| XENCOR, INC. | Corporate Officer/Principal | - |
Opleiding van Debra Zack
| Texas Christian University | Undergraduate Degree |
| The University of Texas Southwestern Medical Center | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| XENCOR, INC. | Health Technology |
| EXAGEN INC. | Health Services |
